163 related articles for article (PubMed ID: 7660337)
1. Relation between beta-lactamase producing bacteria and patient characteristics in chronic obstructive pulmonary disease (COPD).
Sportel JH; Koëter GH; van Altena R; Löwenberg A; Boersma WG
Thorax; 1995 Mar; 50(3):249-53. PubMed ID: 7660337
[TBL] [Abstract][Full Text] [Related]
2. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993.
Nissinen A; Grönroos P; Huovinen P; Herva E; Katila ML; Klaukka T; Kontiainen S; Liimatainen O; Oinonen S; Mäkelä PH
Clin Infect Dis; 1995 Nov; 21(5):1193-6. PubMed ID: 8589142
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of patients with beta-lactamase producing Haemophilus influenzae isolated from sputum.
Johnson SR; Thompson RC; Humphreys H; Macfarlane JT
J Antimicrob Chemother; 1996 Nov; 38(5):881-4. PubMed ID: 8961060
[TBL] [Abstract][Full Text] [Related]
4. The epidemiology of respiratory tract pathogens in southern Netherlands.
Davies BI; Maesen FP
Eur Respir J; 1988 May; 1(5):415-20. PubMed ID: 3139445
[TBL] [Abstract][Full Text] [Related]
5. Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis.
Bogdanovich T; Clark C; Ednie L; Lin G; Smith K; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2006 Jun; 50(6):2050-7. PubMed ID: 16723565
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Pottumarthy S; Sader HS; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2005 Nov; 53(3):225-31. PubMed ID: 16257168
[TBL] [Abstract][Full Text] [Related]
7. [Serotype distribution and drug resistance of
Tian HL; Shi W; Zhou HF; Yuan L; Yao KH; Rexiati D; Xu AM
Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):279-283. PubMed ID: 29614568
[No Abstract] [Full Text] [Related]
8. Production of betalactamase by respiratory tract bacteria in children: relationship to antibiotic use.
Mölstad S; Arvidsson E; Eliasson I; Hovelius B; Kamme C; Schalén C
Scand J Prim Health Care; 1992 Mar; 10(1):16-20. PubMed ID: 1589657
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility and beta-lactamase production of Moraxella catarrhalis isolates in Taiwan.
Fung CP; Jang TN; Liu CY; Lau YJ; Liu YC; Chuang YC; Lee N
J Formos Med Assoc; 1995 Sep; 94(9):548-54. PubMed ID: 8696169
[TBL] [Abstract][Full Text] [Related]
11. Bacteriology in acute exacerbation of chronic obstructive pulmonary disease in patients admitted to hospital.
Larsen MV; Janner JH; Nielsen SD; Friis-Møller A; Ringbaek T; Lange P
Scand J Infect Dis; 2009; 41(1):26-32. PubMed ID: 18855228
[TBL] [Abstract][Full Text] [Related]
12. Isolation of Moraxella catarrhalis from sputum specimens of Malaysian patients.
Ahmad N; Cheong YM; Tahir HM
Malays J Pathol; 1994 Jun; 16(1):63-7. PubMed ID: 16329578
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
[TBL] [Abstract][Full Text] [Related]
14. Individual use of antibiotics and prevalence of beta-lactamase production among bacterial pathogens from middle ear fluid.
Thrane N; Olesen C; Sørensen HT; Schønheyder HC
J Antimicrob Chemother; 2001 Feb; 47(2):211-4. PubMed ID: 11157910
[TBL] [Abstract][Full Text] [Related]
15. Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.
Yourassowsky E; Van der Linden MP; Crokaert F
Chemotherapy; 1992; 38(1):7-13. PubMed ID: 1618006
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.
Yang Q; Xu Y; Chen M; Wang H; Sun H; Hu Y; Zhang R; Duan Q; Zhuo C; Cao B; Liu Y; Yu Y; Sun Z; Chu Y
Diagn Microbiol Infect Dis; 2012 Jun; 73(2):187-91. PubMed ID: 22521692
[TBL] [Abstract][Full Text] [Related]
17. Ampicillin resistance in
Maddi S; Kolsum U; Jackson S; Barraclough R; Maschera B; Simpson KD; Pascal TG; Durviaux S; Hessel EM; Singh D
Int J Chron Obstruct Pulmon Dis; 2017; 12():1507-1518. PubMed ID: 28579769
[TBL] [Abstract][Full Text] [Related]
18. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
[TBL] [Abstract][Full Text] [Related]
19. Sputum microbiology in a district general hospital. The role of Branhamella catarrhalis.
Mannion PT
Br J Dis Chest; 1987 Oct; 81(4):391-6. PubMed ID: 3130089
[TBL] [Abstract][Full Text] [Related]
20. [Pathogenesis of beta-lactam-resistant Haemophilus influenzae isolated from sputum].
Watanuki Y; Odagiri S; Takahashi H; Ogura T; Tomioka T
Kansenshogaku Zasshi; 2004 Oct; 78(10):873-8. PubMed ID: 15560377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
